van der Horst-Bruinsma I E, de Vries R R, de Buck P D, van Schendel P W, Breedveld F C, Schreuder G M, Hazes J M
Department of Rheumatology, Leiden University Medical Centre, The Netherlands.
Ann Rheum Dis. 1998 May;57(5):286-90. doi: 10.1136/ard.57.5.286.
To assess the relation between the course of rheumatoid arthritis (RA) during pregnancy or the onset of RA postpartum and DRB1, DQA1, and DQB1 incompatibilities between mother and child.
In 45 pregnancies of 33 RA patients the course of RA was related to the number of class II incompatibilities. Furthermore class II incompatibilities in 16 pregnancies followed by RA onset were compared with those in 87 control pregnancies.
The risk of a favourable compared with an unfavourable course was 0.95, 2.67, and 2.38 in case of DRB1, DQA1, and DQB1 incompatibility respectively. DQA1 and DQB1 incompatibilities were seen more often in the 10 pregnancies followed by RA onset within three months than in control pregnancies (OR 8.02, 95% CI 0.97, 66.06 and OR 8.79 95% CI 1.07, 72.46 respectively).
DQA1 and DQB1 incompatibility between mother and child seems to have a favourable effect on the course of RA and may postpone the risk of RA onset during pregnancy.
评估孕期类风湿关节炎(RA)病程或产后RA发病与母婴之间DRB1、DQA1和DQB1不相容性的关系。
在33例RA患者的45次妊娠中,RA病程与II类不相容性的数量相关。此外,将16例妊娠后发生RA的II类不相容性与87例对照妊娠中的II类不相容性进行比较。
DRB1、DQA1和DQB1不相容时,病情转好与转差的风险分别为0.95、2.67和2.38。在妊娠后三个月内发生RA的10例妊娠中,DQA1和DQB1不相容的情况比对照妊娠中更常见(OR分别为8.02,95%CI 0.97,66.06和OR 8.79,95%CI 1.07,72.46)。
母婴之间的DQA1和DQB1不相容似乎对RA病程有有利影响,并可能推迟孕期RA发病的风险。